{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:21:36Z","timestamp":1789410096054,"version":"build-2803163510"},"reference-count":4,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Scott Med J"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:p>Cyclizine is commonly prescribed as an anti-emetic post-operatively. We report a case of a 51-year-old woman who developed addiction to intravenous cyclizine following regular administration at recommended doses. This is the first report of cyclizine misuse post-operatively. We compare this case to cyclizine abuse reported amongst other populations. Prescribers should be aware of the potential of cyclizine as a drug of abuse.<\/jats:p>","DOI":"10.1177\/0036933013508039","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T11:39:02Z","timestamp":1383910742000},"page":"e1-e2","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Post-operative cyclizine misuse"],"prefix":"10.1177","volume":"58","author":[{"given":"J","family":"Woodfield","sequence":"first","affiliation":[{"name":"Neurosurgery Specialty Trainee, Institute of Neurological Sciences, Southern General Hospital, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EJ","family":"St George","sequence":"additional","affiliation":[{"name":"Consultant Neurosurgeon, Institute of Neurological Sciences, Southern General Hospital, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,11,8]]},"reference":[{"key":"bibr1-0036933013508039","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2012","edition":"63"},{"key":"bibr2-0036933013508039","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1989.tb00766.x"},{"key":"bibr3-0036933013508039","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-6757(96)90156-4"},{"key":"bibr4-0036933013508039","doi-asserted-by":"publisher","DOI":"10.1177\/0269216308094337"}],"container-title":["Scottish Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0036933013508039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0036933013508039","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0036933013508039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:15:44Z","timestamp":1777630544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0036933013508039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1177\/0036933013508039"],"URL":"https:\/\/doi.org\/10.1177\/0036933013508039","relation":{},"ISSN":["0036-9330","2045-6441"],"issn-type":[{"value":"0036-9330","type":"print"},{"value":"2045-6441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}